• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.住院化脓性汗腺炎患者的慢性肾脏病风险。
Dermatology. 2023;239(6):912-918. doi: 10.1159/000531960. Epub 2023 Jul 24.
2
Risk of respiratory diseases among hospitalized patients with hidradenitis suppurativa.住院化脓性汗腺炎患者的呼吸道疾病风险。
Int J Dermatol. 2024 Nov;63(11):1528-1534. doi: 10.1111/ijd.17182. Epub 2024 Apr 18.
3
Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.化脓性汗腺炎是一种系统性疾病,具有较大的合并症负担:基于图表验证的病例对照分析。
J Am Acad Dermatol. 2014 Dec;71(6):1144-50. doi: 10.1016/j.jaad.2014.09.012. Epub 2014 Oct 14.
4
Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.美国化脓性汗腺炎患者 2 型糖尿病的患病率。
J Am Acad Dermatol. 2018 Jul;79(1):71-76. doi: 10.1016/j.jaad.2018.01.014. Epub 2018 Jan 12.
5
Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.患有化脓性汗腺炎的人群患银屑病的风险:系统评价和荟萃分析。
Front Immunol. 2022 Dec 1;13:1033844. doi: 10.3389/fimmu.2022.1033844. eCollection 2022.
6
Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.筛查患有化脓性汗腺炎的患者中的糖尿病——德国的一项单中心研究。
Int J Mol Sci. 2023 Apr 1;24(7):6596. doi: 10.3390/ijms24076596.
7
Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study.化脓性汗腺炎患者心血管疾病发病风险:一项大规模、倾向评分匹配的全球回顾性队列研究。
Int J Dermatol. 2024 Jun;63(6):799-805. doi: 10.1111/ijd.17186. Epub 2024 Apr 21.
8
Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population-based cohort study.韩国 17 年来的化脓性汗腺炎流行病学和合并症:一项全国基于人群的队列研究。
J Dermatol. 2023 Jun;50(6):778-786. doi: 10.1111/1346-8138.16747. Epub 2023 Feb 20.
9
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.UNITE 研究的基线特征:一项评估临床实践中化脓性汗腺炎(反向痤疮)的观察性、国际性、多中心登记研究。
Am J Clin Dermatol. 2020 Aug;21(4):579-590. doi: 10.1007/s40257-020-00504-4.
10
Association of metabolic syndrome and hidradenitis suppurativa.代谢综合征与化脓性汗腺炎的相关性。
JAMA Dermatol. 2014 Dec;150(12):1273-80. doi: 10.1001/jamadermatol.2014.1165.

引用本文的文献

1
IRAK4 Targeting: A Breakthrough Approach to Combat Hidradenitis Suppurativa.靶向IRAK4:治疗化脓性汗腺炎的突破性方法。
Biologics. 2025 Jun 30;19:387-397. doi: 10.2147/BTT.S525106. eCollection 2025.
2
Renal dysfunction in people with hidradenitis suppurativa: a multi-center, propensity-score-matched cohort study.化脓性汗腺炎患者的肾功能障碍:一项多中心、倾向评分匹配队列研究。
Int J Med Sci. 2025 Jan 1;22(3):558-564. doi: 10.7150/ijms.102434. eCollection 2025.
3
A Neglected Disease: Hidradenitis Suppurativa a Rare Cause of Amyloidosis Complicated With Sepsis and Renal Failure: A Case Report.一种被忽视的疾病:化脓性汗腺炎——淀粉样变性合并脓毒症及肾衰竭的罕见病因:一例报告
Case Rep Crit Care. 2024 Aug 27;2024:4893040. doi: 10.1155/2024/4893040. eCollection 2024.

本文引用的文献

1
Inflammatory skin diseases and the risk of chronic kidney disease: population-based case-control and cohort analyses.炎症性皮肤病与慢性肾脏病风险:基于人群的病例对照和队列分析。
Br J Dermatol. 2021 Oct;185(4):772-780. doi: 10.1111/bjd.20067. Epub 2021 Jun 6.
2
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.化脓性汗腺炎的共病筛查:美国和加拿大化脓性汗腺炎基金会的循证建议
J Am Acad Dermatol. 2022 May;86(5):1092-1101. doi: 10.1016/j.jaad.2021.01.059. Epub 2021 Jan 23.
3
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病早期识别与干预的理由:来自改善全球肾脏病预后组织(KDIGO)争议会议的结论
Kidney Int. 2021 Jan;99(1):34-47. doi: 10.1016/j.kint.2020.10.012. Epub 2020 Oct 27.
4
Disease Trajectories for Hidradenitis Suppurativa in the Danish Population.丹麦人群中化脓性汗腺炎的疾病进程。
JAMA Dermatol. 2020 Jul 1;156(7):780-786. doi: 10.1001/jamadermatol.2020.1281.
5
Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.化脓性汗腺炎:流行病学、临床表现和发病机制。
J Am Acad Dermatol. 2020 May;82(5):1045-1058. doi: 10.1016/j.jaad.2019.08.090. Epub 2019 Oct 9.
6
The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.化脓性汗腺炎对生活质量的广泛影响:与银屑病的比较。
Dermatology. 2019;235(4):308-314. doi: 10.1159/000496604. Epub 2019 May 23.
7
Determining the optimal dose of infliximab for treatment of hidradenitis suppurativa.确定英夫利昔单抗治疗化脓性汗腺炎的最佳剂量。
J Am Acad Dermatol. 2019 Sep;81(3):702-708. doi: 10.1016/j.jaad.2019.05.022. Epub 2019 May 13.
8
Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.比较化脓性汗腺炎患者的总体合并症负担。
JAMA Dermatol. 2019 Jul 1;155(7):797-802. doi: 10.1001/jamadermatol.2019.0164.
9
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management.北美化脓性汗腺炎临床管理指南:美国和加拿大化脓性汗腺炎基金会的出版物:第一部分:诊断、评估和补充及程序管理的应用。
J Am Acad Dermatol. 2019 Jul;81(1):76-90. doi: 10.1016/j.jaad.2019.02.067. Epub 2019 Mar 11.
10
A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa.化脓性汗腺炎中炎症细胞因子关联的系统评价与批判性评估
F1000Res. 2018 Dec 13;7:1930. doi: 10.12688/f1000research.17267.1. eCollection 2018.

住院化脓性汗腺炎患者的慢性肾脏病风险。

Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.

机构信息

Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

出版信息

Dermatology. 2023;239(6):912-918. doi: 10.1159/000531960. Epub 2023 Jul 24.

DOI:10.1159/000531960
PMID:37487485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10711764/
Abstract

BACKGROUND

Hidradenitis suppurativa (HS) is associated with several comorbidities such as diabetes mellitus and cardiovascular diseases. These comorbidities are also risk factors for chronic kidney disease (CKD), yet little is known about the risk of CKD in HS patients.

OBJECTIVES

The objective was to study the prevalence of CKD in HS patients.

METHODS

Cross-sectional population-based study using the United States National Inpatient Sample database between January 1, 2002 and December 31, 2012 was performed.

RESULTS

We identified 23,767 hospital admissions for HS patients and 95,068 admissions for age- and gender-matched controls. The prevalence of CKD in HS patients was 6.3% (1,497/23,767) compared to non-HS controls which was 4.3% (4,052/95,068). The association of CKD was strongest in HS patients, who were ≥60 years old, 16.9% (475/2,811), male 7.3% (695/9,556), obese 7.8% (407/5,209), diabetic 12.5% (890/7,105), hyperlipidemic 13.3% (416/3,126), and had cardiovascular diseases 12.5% (631/5,045). The crude odds ratio of CKD in HS patients was 1.5 (95% CI: 1.420-1.605) compared to non-HS patients. The association remained significant after adjusting for important covariates with adjusted odds ratio of CKD in HS patients of 1.1 (95% CI: 1.014-1.176) compared to non-HS patients.

CONCLUSIONS

Our findings show that there is a possible association of HS with CKD. Any signs of CKD should be assessed by a nephrologist as early diagnosis can hopefully prevent further progression.

摘要

背景

化脓性汗腺炎(HS)与多种合并症相关,如糖尿病和心血管疾病。这些合并症也是慢性肾脏病(CKD)的危险因素,但关于 HS 患者发生 CKD 的风险知之甚少。

目的

研究 HS 患者 CKD 的患病率。

方法

使用美国国家住院患者样本数据库,于 2002 年 1 月 1 日至 2012 年 12 月 31 日进行了一项基于人群的横断面研究。

结果

我们共确定了 23767 例 HS 患者和 95068 例年龄和性别匹配的对照患者的住院记录。与非 HS 对照患者(4.3%,4052/95068)相比,HS 患者 CKD 的患病率为 6.3%(1497/23767)。CKD 与 HS 之间的关联在年龄≥60 岁的 HS 患者中最强(16.9%,475/2811)、男性(7.3%,695/9556)、肥胖(7.8%,407/5209)、糖尿病(12.5%,890/7105)、血脂异常(13.3%,416/3126)和心血管疾病(12.5%,631/5045)患者中最强。与非 HS 患者相比,HS 患者的 CKD 粗比值比为 1.5(95%CI:1.420-1.605)。在校正了重要协变量后,HS 患者的 CKD 调整比值比为 1.1(95%CI:1.014-1.176),与非 HS 患者相比仍然显著。

结论

我们的研究结果表明,HS 与 CKD 之间可能存在关联。任何 CKD 迹象都应通过肾病学家进行评估,因为早期诊断有望防止进一步进展。